|

Methoxyamine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TRC102 Base

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Lung Large Cell Carcinoma1
  • Lung Non-Squamous Non-Small Cell Carcinoma1
  • Lung Adenocarcinoma1
  • Stage III Lung Cancer AJCC v81
  • Lung Cancer1

Buena Park, California1 trial

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Keck Medicine of USC Buena Park

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.